DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Biologic Drugs cited in Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2015-05-05||1||Complaint||7,270,826; 7,335,367; 7,459,164; 7,491,403; 7,537,773; 7,670,608; 7,691,394; 7,943,152; 8,580,745; 8,691,769…knowledge and owns composition and application patents for PurTox that are complementary to the purified…purified neurotoxin technology, including U.S. Patent Nos. 5,401,243; 5,298,019; 5,696,077; 6,429,189; 7,270,826…notice to WARF. 29. BTRA identified a patent infringement issue by Allergan, Inc. during this… Johnson objected stating that the transfer of patent enforcement claims would "be contrary to the||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|